How Red Light Therapy Works: Why Light Influences Mitochondria, Energy and Cellular Regeneration
When someone searches “how does red light therapy work?”, they usually do not want only the technical specifications of a panel. They want to understand something much more fundamental: how can light falling on the body influence a living cell at all?
This is where many marketing shortcuts begin. Red light is said to “charge mitochondria”, “give cells energy”, “increase ATP”, “activate regeneration” or simply “switch cells on”. Each of these statements contains a small piece of the biological story, but none of them describes the mechanism in full.
Red light therapy — more precisely, photobiomodulation — works by allowing an optical stimulus to interact with biological tissue, where some photons are absorbed by molecular structures and that interaction can alter cellular signalling. Mitochondria are among the most important sites being investigated, but they are not the only possible origin of a photobiological response. Contemporary mechanistic literature therefore no longer treats PBM as one simple pathway from light to ATP, but rather as a network of interconnected photochemical, redox, ionic and metabolic processes.
As a first orientation map, the mechanism can be simplified as follows:
PHOTON → ABSORPTION / PHOTOACCEPTOR → SECONDARY SIGNAL → CELLULAR RESPONSE → TISSUE OUTCOME
This sequence is not a complete model of PBM. It is simply a first map that helps us understand where photobiomodulation begins between the physics of light and the eventual biological outcome.
The shortest answer: how does red light therapy actually work?
Red and near-infrared light carry electromagnetic energy in the form of photons. When light reaches tissue, some is reflected, some is scattered and some is absorbed. If a photon is absorbed by a molecule or molecular system capable of responding to that wavelength, it can alter its physical or chemical state. That initial event may subsequently influence the redox environment, nitric oxide, ionic signalling, mitochondrial function or other regulatory processes.
The cell therefore does not receive a finished outcome.
It receives a physical stimulus that it may translate into a biological signal.
That is the foundation of photobiomodulation.
Light carries energy — but it is not metabolic fuel
One of the most important corrections to older explanations of red light therapy is this: it is not correct to say that “light is not energy”.
Light carries physical energy.
Electromagnetic radiation is composed of photons, and the energy of an individual photon depends on its frequency and therefore, indirectly, on its wavelength.
The error begins when that physical energy is interpreted as though red light were metabolic fuel for the cell. A photon is not converted directly into an ATP molecule, and a light panel does not replace glucose, fatty acids, oxygen or mitochondrial metabolism.
A more accurate formulation is therefore:
Light provides a physical stimulus. The cell generates its metabolic outcome through its own biological processes.
The distinction may appear small at first.
In reality, it changes the entire way the technology should be understood.
Photobiomodulation: when a physical stimulus changes a biological response
The scientific term photobiomodulation — PBM describes the use of low-intensity light exposures to modulate biological processes without the primary aim of heating, damaging or surgically altering tissue. Modern reviews emphasise that the result depends on light–tissue interaction, tissue composition, the biological target and a rationally selected dose.
That is why not every source of red light automatically constitutes meaningful photobiomodulation.
Red colour is a visual property of light.
PBM is a biological response to a specific optical exposure.
These are not the same thing.
Why mitochondria matter so much in red light therapy
Mitochondria are often described as the “powerhouses of the cell”. That analogy helps explain their role in ATP production, but it is highly incomplete.
Mitochondria are also regulatory hubs. They participate in redox signalling, metabolic flexibility, Ca²⁺ homeostasis, apoptosis, ROS production, stress adaptation and communication between cellular metabolism and gene expression. A change in mitochondrial state can therefore matter for much more than ATP concentration alone.
This is why mitochondria are among the leading candidates for explaining photobiomodulation. Numerous experimental studies have reported changes in mitochondrial respiration, membrane potential, ATP, redox state and secondary signalling molecules following exposure to red or near-infrared light.
That does not mean the mitochondrion behaves like a solar panel.
It is more accurate to think of it as one of the regulatory hubs at which an optical stimulus may alter the state of the cell.
Cytochrome c oxidase: the leading model, but not a definitively solved mechanism
The best-known mechanistic model of PBM focuses on cytochrome c oxidase — CCO, complex IV of the mitochondrial electron transport chain. CCO participates in transferring electrons to oxygen and in generating the electrochemical gradient subsequently used by ATP synthase.
A long-standing hypothesis proposes that red or near-infrared photons may interact with chromophores within CCO and thereby alter mitochondrial respiration. One proposed mechanism is the photodissociation of inhibitory nitric oxide from CCO, which under certain conditions could influence its activity.
This model is biologically compelling and remains highly important.
It would not, however, be scientifically accurate to present it as the definitive and universal mechanism of PBM.
A critical review by Quirk and Whelan pointed out that direct and reproducible evidence for light-induced changes in CCO is less unequivocal than is often suggested in popular descriptions. The authors therefore emphasised the role of NO while also highlighting that the mechanism of PBM remains an open scientific question.
TANVEA therefore does not use the sentence:
“Red light activates cytochrome c oxidase.”
A more accurate formulation is:
Cytochrome c oxidase is one of the most important candidate photoacceptors studied in PBM, but the entire mechanism cannot be reduced to CCO alone.
Nitric oxide: a small molecule with major significance
Nitric oxide — NO — is an important signalling molecule involved in vascular tone, mitochondrial function, cellular communication and many other processes.
Within mechanistic models of PBM, NO is frequently discussed in relation to CCO. Under certain metabolic conditions, NO can interact with complex IV and influence mitochondrial respiration. Some hypotheses and experimental findings suggest that light may alter NO binding or availability and thereby modify the mitochondrial and redox environment. Critical reviews, however, show that this pathway is not simple and that its relevance can vary with wavelength, redox state, oxygen concentration and the experimental system.
In simplified terms, NO can be thought of as one of the molecules capable of temporarily altering the setting of mitochondrial respiration. Under certain conditions, its interaction with cytochrome c oxidase may act as a partial brake on electron transport, and light may influence that interaction. It is not, however, a universal “brake pedal” that red light simply releases every time — the importance of NO depends on cellular redox state, oxygen concentration, spectrum, light dose and other conditions.
It is therefore misleading to reduce the mechanism to:
“660 nm pushes NO out of the mitochondrion and increases ATP.”
Biology is considerably more complex.
ROS: not only damage, but also information
Reactive oxygen species — ROS — are often discussed only in the context of oxidative stress and cellular damage. At high or chronically elevated levels, that can indeed be true.
At low and transient concentrations, however, ROS also function as secondary signalling molecules.
In some experimental models, photobiomodulation can induce a temporary change in the mitochondrial redox environment and signalling-related ROS production. Such a pulse may subsequently influence transcription factors, gene expression and cellular adaptive mechanisms.
This is why PBM cannot be understood as a simple “antioxidant made of light”.
A more accurate model is:
optical stimulus → change in redox signalling → regulatory response
Magnitude, timing and biological context all matter.
Ca²⁺, ion channels and other photoacceptors: the mechanism extends beyond mitochondria
Contemporary PBM research is not limited to mitochondria and CCO. Light-sensitive ion channels, including members of the TRP family, as well as opsins, flavins, porphyrins and other molecular structures capable of responding to different regions of the electromagnetic spectrum are also being studied.
Activation of ion channels can alter intracellular Ca²⁺ concentrations, membrane potential and downstream signalling pathways. Ca²⁺ is one of the fundamental universal secondary messengers in cells and influences metabolism, gene expression, contraction, secretion and adaptive responses.
The modern mechanistic picture of PBM therefore looks more like a network of parallel and interconnected pathways than a single straight line from CCO to ATP. Current reviews consequently emphasise not only mitochondria but also other photoacceptors, ionic signalling and the fundamental importance of target-tissue properties.
What about ATP? Increases have been observed, but there is no universal equation
ATP is the principal carrier of chemical energy within the cell, and mitochondria contribute substantially to its production through oxidative phosphorylation.
Changes in ATP or mitochondrial metabolism have been observed after optical exposure in many experimental PBM models. This gave rise to the popular statement:
“Red light therapy increases ATP.”
That statement is too broad.
The result depends on the cellular model, baseline state, wavelength, irradiance, dose and timing of measurement. Moreover, an experimental increase in ATP does not, by itself, explain a specific clinical outcome in a human being.
A particularly interesting example is a 2025 study examining the direct effects of 635 nm light on isolated mitochondria. The results did not show a simple linear relationship of “more light = more ATP”. Different exposures altered respiration, proton leak and susceptibility of the mitochondrial membrane to changes in permeability. The authors therefore emphasised that the effects of light on mitochondrial bioenergetics are transient, local and mechanistically complex.
This is a particularly important lesson for TANVEA:
ATP is part of the mechanistic story of PBM. It is not a universal measure of its effect.
Why “more cellular energy” does not automatically mean more subjective human energy
Whenever the word energy appears in a discussion of mitochondria, two completely different levels can easily become confused.
The first is cellular bioenergetics — electron transport, membrane potential, oxidative phosphorylation and ATP.
The second is subjective human energy — vitality, fatigue, performance or the ability to concentrate.
There is no simple equation connecting the two.
Human fatigue can be influenced by sleep, psychological stress, infection, metabolic disease, insufficient dietary energy intake, anaemia, hormonal factors, physical conditioning and many other variables.
A mechanistic observation involving mitochondrial signalling therefore does not justify the claim:
“Red light gives you energy.”
A more accurate statement is:
Under certain exposure parameters, PBM may influence processes related to cellular bioenergetics.
Whether that becomes subjectively experienced as “more energy” is an entirely different clinical question.
How can a cellular signal become regeneration?
The phrase cellular regeneration is popular, but biologically it requires greater precision.
Cells can adapt, repair damaged structures, alter metabolism, proliferate, differentiate, or activate stress-response and protective programmes. Tissue regeneration is an even more complex process involving extracellular matrix, vasculature, immune cells, neural signals, stem or progenitor cells and communication between multiple cell types.
PBM therefore does not “switch regeneration on” through one mechanism.
The mechanistic logic is closer to:
optical stimulus → cellular signalling → altered cellular behaviour → altered tissue environment → possible change in repair or function
This is exactly where it becomes essential to separate mechanism from outcome. The fact that we can describe a biologically plausible cellular pathway does not, by itself, prove that a person will heal faster, experience less pain or recover better.
The clinical outcome must be demonstrated in clinical research.
630, 660, 810, 830 or 850 nm: why these wavelengths are used, and why the number is not enough
Red light therapy commonly uses red wavelengths roughly within the 620–700 nm range and near-infrared wavelengths roughly within the 780–1,100 nm range. Specific devices often use wavelengths such as 630, 660, 810, 830 or 850 nm.
These numbers are not biological “addresses”.
Different wavelengths have different absorption and scattering properties. Their distribution through tissue is influenced by melanin, haemoglobin, water, fat, connective tissue, anatomical geometry and the configuration of the source itself.
It is therefore inaccurate to say:
“660 nm goes into the skin and 850 nm goes into muscle.”
A more precise formulation is:
Different spectral regions create different conditions for light–tissue interaction, and the resulting biological exposure depends on the entire system, not merely the number stated in nanometres.
This is why TANVEA speaks about optical architecture, not a collection of wavelengths.
Dose matters — but dosing belongs to its own information territory
Whether light creates a biologically relevant stimulus depends not only on spectrum, but also on irradiance, radiant exposure, time, distance, geometry, treatment area, pulsing and frequency of repetition.
PBM also demonstrates a non-linear and, in many experimental systems, biphasic dose response. The mechanism therefore cannot be understood as a linear equation:
more photons → more ATP → more regeneration
No such universal equation exists.
This article deliberately does not explore dosing in detail, because that information territory belongs to Red Light Therapy at Home: What Determines Whether It Works or Not and the practical SCHOOLS article How to Use Red Light Therapy: The Most Common Mistakes That Limit the Body’s Response.
For this article, one principle is enough:
The mechanism of PBM cannot be separated from the dose at which it occurs.
Why the same stimulus may not produce the same cellular response
A biological system is not inert material.
The same optical stimulus may produce a different response in a healthy cell, a cell under metabolic stress or a cell with a different redox state. Mechanistic literature has long highlighted differences between healthy and stressed cells and the importance of the baseline biological state.
This should not, however, be confused with the older idea that a person must have a “prepared body”, better microcirculation, more oxygen, a relaxed nervous system or another TANVEA modality before PBM can work.
There is no universal evidence for such a requirement.
A more accurate model is:
The biological state of the target tissue can influence its response to an optical stimulus, but there is no universal checklist of conditions that must be fulfilled before PBM can work.
This distinction between biological context and unproven synergy is extremely important.
Mitochondria need oxygen — but that does not create a mandatory Oxygen Systems™ sequence
Oxidative phosphorylation does, of course, depend on oxygen. Molecular oxygen is the terminal electron acceptor in the mitochondrial respiratory chain.
But this basic physiological fact does not allow us to conclude that a person must increase oxygen delivery before PBM or that hyperbaric oxygenation, oxygen exposure or another Oxygen Systems™ modality will automatically enhance the effect of red light therapy.
That would be a logical leap from physiology to an unproven clinical synergy.
TANVEA Biological Systems™ are therefore not understood as a mandatory sequence of procedures.
We understand them as distinct physical and biological inputs into one living organism, whose mechanisms should be evaluated independently and whose combinations should be considered only where biological and clinical evidence supports them.
Mechanism is not a clinical outcome
This distinction is fundamental in an article explaining how red light therapy works.
We may have highly interesting experimental data on CCO, ATP, ROS, NO, Ca²⁺, membrane potential or gene expression.
That does not mean a person will automatically experience less pain, thicker hair or faster healing.
Mechanism answers the question:
“How could the biological effect arise?”
Clinical evidence answers a different question:
“Does an outcome that actually matters to a human being change?”
TANVEA therefore clearly separates:
MECHANISTIC EVIDENCE
from
CLINICAL EVIDENCE
This information territory also defines the boundary between this article and the separate DISCOVER article Red Light Therapy Effects: What Really Happens in Cells and Why It Is Not Just About the Skin.
This article explains how.
The effects article evaluates what has actually been observed in humans.
The TANVEA mechanistic framework: from photon to outcome
Now that the individual mechanisms have been explained, we can expand the initial orientation map to include the biological state of the cell and the pathway towards an outcome.
PHOTON
What light and what photon energy enter the system?
↓
ABSORPTION
Which molecular structures or photoacceptors absorb that light?
↓
SIGNAL
How are NO, ROS, Ca²⁺, redox state, mitochondrial function or other secondary signals altered?
↓
CELL STATE
How does the cell interpret that signal within its current metabolic and regulatory state?
↓
RESPONSE
Do gene expression, metabolism, proliferation, differentiation, stress response or communication with the surrounding environment change?
↓
TISSUE OUTCOME
Does the cellular change translate into a measurable change in tissue function or repair?
This framework is not a simple linear pathway. Feedback loops exist between the individual levels, and not every photon, molecular signal or cellular change necessarily leads to a clinically meaningful result.
That is precisely why photobiomodulation is more interesting than the marketing sentence “light increases ATP”.
TANVEA Light Systems™: from a list of specifications to optical architecture
If the mechanism depends on what light reaches which tissue, at what dose and with what geometry, then the quality of a light system cannot be judged by one number.
Not by LED count.
Not by maximum irradiance.
Not by whether a panel lists five wavelengths or seven.
And not by electrical input power alone.
At TANVEA Light Systems™, we therefore treat spectrum, irradiance, light-field uniformity, optics, geometry, working distance and dose control as one integrated optical architecture.
Its purpose is not to “charge the body”.
Its purpose is to create a defined and reproducible physical stimulus that can be understood biologically.
That is the difference between a panel as an appliance and light as a system.
What does it really mean to say that red light therapy “supports cellular regeneration”?
This phrase can be useful as shorthand, but it should not create the impression that light itself repairs the cell.
Under appropriate exposure conditions, PBM can influence regulatory processes related to metabolism, redox state, cell survival, proliferation, differentiation and communication between cells. Within a specific tissue and clinical context, these changes may contribute to repair or a regenerative response.
But the panel itself does not create regeneration.
The outcome emerges from the interaction of:
optical stimulus × target tissue × cell state × dose × time
It is therefore much more accurate to speak of modulation of biological processes involved in repair and regenerative responses than to say that “light regenerates cells”.
Where are the current limits of mechanistic knowledge?
The mechanism of PBM is biologically well supported in the sense that we have extensive experimental data involving mitochondrial, redox, NO and Ca²⁺ signalling as well as other candidate photoacceptors.
What we still do not have is one universal molecular pathway capable of explaining every wavelength, every cell type, every dose and every clinical result.
That is not a weakness of the field.
It is the reality of complex biology.
Current state-of-the-art reviews therefore emphasise that light–tissue interaction, biological target and dosing must be understood as one integrated problem. Newer experiments also show that immediate mitochondrial responses can be considerably more complex than the simple model “more light → more ATP” suggests.
TANVEA therefore treats scientific uncertainty as part of precision, not as something that should be hidden by marketing.
Conclusion: red light therapy works as a physical input into biological regulation
Red light therapy does not work like a charger for cells.
Photons are not converted directly into ATP.
Mitochondria are not switched on like a light switch.
And regeneration does not happen simply because a panel emits red light.
Light does, however, carry physical energy and, under appropriate exposure conditions, can interact with biological molecules and systems. That interaction can alter mitochondrial function, redox signalling, NO, Ca²⁺ and other regulatory pathways that subsequently influence cellular behaviour.
The most accurate answer to the question “how does red light therapy work?” is therefore:
Red light therapy creates a defined physical optical stimulus that can be absorbed by biological tissue and translated into cellular signalling. The resulting response depends on spectrum, dose, target tissue and biological context — and only subsequently may lead to a measurable change in function or repair.
Light is therefore not the finished outcome.
It is the input.
The cell is the interpreting system.
And the biological outcome emerges in the interaction between the two.
That is the essence of photobiomodulation.
FAQ
How does red light therapy work?
Red light therapy primarily uses red and near-infrared light to create a biologically relevant optical exposure. Some photons are absorbed within tissue and may influence mitochondrial, redox, NO, Ca²⁺ and other cellular signalling pathways. The cell can then alter its regulatory response.
Is red light therapy the same as photobiomodulation?
Not exactly. Red light therapy is a broad consumer term. Photobiomodulation is a more precise scientific term for a defined, non-invasive light intervention in which a specific optical exposure modulates a biological response.
Does red light therapy give cells energy?
Not in the metabolic sense. Light carries physical energy, but photons are not converted directly into ATP and do not replace metabolic fuels. Light may influence processes related to mitochondrial and cellular bioenergetics.
Does red light therapy affect mitochondria?
Yes. Mitochondria are among the most extensively studied sites involved in PBM. Research describes changes in mitochondrial respiration, redox signalling, membrane potential and ATP, but the response depends on experimental conditions and dose.
What is cytochrome c oxidase and why is it discussed in PBM?
Cytochrome c oxidase is complex IV of the mitochondrial electron transport chain. It is one of the leading candidate photoacceptors for red and near-infrared light. It has not, however, been definitively proven to explain the entire mechanism of PBM on its own.
Does red light therapy increase ATP?
Changes or increases in ATP have been observed in some experimental models. It is not accurate to claim that every PBM exposure automatically increases ATP. The result depends on cellular state, spectrum, dose and timing of measurement.
What role does nitric oxide play in red light therapy?
NO is an important signalling molecule. In some mechanistic models, its interaction with cytochrome c oxidase may temporarily influence mitochondrial respiration, and light may modify that interaction. It is not, however, a universal “brake pedal”; the role of NO depends on redox state, oxygen availability, spectrum and dose.
Are ROS harmful during red light therapy?
Not automatically. High or prolonged ROS levels can be harmful, but low and transient changes in ROS also function as cellular signals. PBM may influence this redox signalling in some experimental models.
Why are 660 nm and 850 nm commonly used?
These wavelengths lie within spectral regions frequently used in PBM because of their optical and biological properties. The wavelength alone does not determine the effect. Irradiance, dose, geometry, working distance and target tissue also matter.
Does a more powerful panel create a greater biological effect?
No. PBM does not have a simple linear dose response. Higher output can be a technical advantage, but the biological outcome depends on the actual exposure and the relevant dose window.
Does the body need to be “prepared” before red light therapy?
There is no known universal set of prerequisites that must be fulfilled before PBM can work. The biological state of the target tissue may influence the response, but sauna, oxygen exposure, hydrotherapy or another modality are not universal requirements for red light therapy to be effective.
Does red light therapy regenerate cells?
A more accurate statement is that, under appropriate exposure conditions, PBM may modulate cellular processes associated with adaptation, repair and regenerative responses. Light does not directly repair the cell, and a mechanistic effect does not automatically translate into a clinical outcome.
SCIENTIFIC REFERENCES AND EVIDENCE BASE
Arany PR.
Photobiomodulation therapy.
JADA Foundational Science. 2025;4:100045.
DOI: 10.1016/j.jfscie.2025.100045.
Current state-of-the-art review of PBM emphasising mechanisms, light–tissue interaction, biological targets, safety and rational dosing.
Frankowski DW, Ferrucci L, Arany PR, et al.
Light buckets and laser beams: mechanisms and applications of photobiomodulation (PBM) therapy.
GeroScience. 2025;47(3):2777–2789.
DOI: 10.1007/s11357-025-01505-z.
Modern mechanistic review of PBM focusing on the complexity of photoacceptors, cellular signalling and biological applications.
Mezzacappo NF, Inada NM, Siqueira-Santos ES, et al.
Exploring Immediate Photon Effects From 635 nm Light on Mitochondrial Bioenergetics.
Journal of Biophotonics. 2025;18(10):e202500162.
DOI: 10.1002/jbio.202500162.
Experimental study in isolated mitochondria showing that the immediate mitochondrial response to red light is dose-dependent, transient and more complex than simple linear stimulation of ATP production.
Quirk BJ, Whelan HT.
What Lies at the Heart of Photobiomodulation: Light, Cytochrome C Oxidase, and Nitric Oxide—Review of the Evidence.
Photobiomodulation, Photomedicine, and Laser Surgery. 2020;38(9):527–530.
DOI: 10.1089/photob.2020.4905.
Critical review of the evidence surrounding CCO and NO, important for scientifically precise interpretation of the CCO hypothesis.
Hamblin MR.
Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation.
Photochemistry and Photobiology. 2018;94(2):199–212.
DOI: 10.1111/php.12864.
Foundational review of mitochondrial and redox signalling and of differences between responses in healthy and stressed cells.
de Freitas LF, Hamblin MR.
Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy.
IEEE Journal of Selected Topics in Quantum Electronics. 2016;22(3).
DOI: 10.1109/JSTQE.2016.2561201.
Classic mechanistic framework for PBM including mitochondria, CCO, NO, ROS, Ca²⁺ and downstream signalling.
Dompe C, Moncrieff L, Matys J, et al.
Photobiomodulation—Underlying Mechanism and Clinical Applications.
Journal of Clinical Medicine. 2020;9(6):1724.
DOI: 10.3390/jcm9061724.
Review of PBM mechanisms and their relationship to cellular behaviour, repair and clinical applications.
Huang YY, Chen ACH, Carroll JD, Hamblin MR.
Biphasic Dose Response in Low Level Light Therapy.
Dose-Response. 2009;7(4):358–383.
DOI: 10.2203/dose-response.09-027.Hamblin.
Foundational framework for the non-linear and biphasic dose response of PBM.
Huang YY, Sharma SK, Carroll J, Hamblin MR.
Biphasic Dose Response in Low Level Light Therapy – an update.
Dose-Response. 2011;9(4):602–618.
DOI: 10.2203/dose-response.11-009.Hamblin.
Expanded dose-response model in relation to mitochondria, ATP and redox signalling.
Zein R, Selting W, Hamblin MR.
Review of light parameters and photobiomodulation efficacy: dive into complexity.
Journal of Biomedical Optics. 2018;23(12):120901.
DOI: 10.1117/1.JBO.23.12.120901.
Key review of wavelength, irradiance, fluence, exposure time, pulsing and other PBM parameters.
SAFETY AND NON-MEDICAL DISCLAIMER
This article is intended for informational and educational purposes. TANVEA Light Systems™ and photobiomodulation devices do not replace diagnosis, medical examination or indicated medical treatment.
The biological response to PBM depends on the specific device, spectrum, dose, target tissue and individual health context. In cases involving photosensitivity, photosensitising medication, significant eye disease, serious medical conditions, or the use of PBM with the intention of influencing a diagnosed disease, it is appropriate to discuss its use with a relevant healthcare professional.
For high-intensity light devices, follow the manufacturer’s instructions regarding eye protection and recommended working distance.
TANVEA EDITORIAL NOTE
This article explains the mechanism of photobiomodulation, not a list of its clinical effects.
Mechanistic plausibility alone does not demonstrate clinical benefit. A change in ATP, ROS, NO, Ca²⁺, mitochondrial membrane potential or gene expression in an experimental model is not automatic proof of a specific outcome in humans.
TANVEA Biological Systems™ also do not imply that Hydro, Thermal, Light, Oxygen and Hydrogen Systems™ must be used together or in a specific sequence. Each system represents a distinct physical or biological input. Their shared architecture exists to help us understand the human being as a biological system, not to create unproven synergies.
IF YOU WANT TO UNDERSTAND RED LIGHT THERAPY, START WITH THE PHOTON — NOT THE MARKETING PROMISE
If you are asking how red light therapy works, do not begin with:
“Light increases ATP.”
Begin more precisely:
“What optical stimulus enters the tissue, what absorbs it, and what biological signalling can that interaction create?”
That is where genuine understanding of photobiomodulation begins.
At TANVEA Light Systems™, we therefore do not view light as a charger or as a competition in watts and nanometres. We view it as a deliberately designed physical input — with spectrum, irradiance, geometry, working distance, dose and target tissue.
If you want to move from mechanism to clinical outcomes, continue with Red Light Therapy Effects: What Really Happens in Cells and Why It Is Not Just About the Skin. If you are interested in the practical side of exposure, continue with Red Light Therapy at Home: What Determines Whether It Works or Not.
You can also experience the principles of optical architecture directly at TANVEA Experience Space™.
Autor: Miroslav Tančin
Zakladateľ TANVEA a tvorca konceptu TANVEA Biological Systems™
Ak máte otázky k článku, k biologickým súvislostiam alebo chcete lepšie pochopiť, ktorý TANVEA systém dáva zmysel práve pre vás, môžete mi napísať priamo na tancin@tanvea.com
Leave your worries behind and get started with our blog
We bring you other articles that will help you get the most out of our products.